Literature DB >> 10714127

[Thrombotic thrombocytopenic purpura (Moschkowitz-syndrome) caused by ticlopidine].

J M Chemnitz1, A Schulz, A Salameh, C Scheid, R Müller, A Draube, V Diehl, D Söhngen.   

Abstract

BACKGROUND: Only in a few case reports the thrombotic thrombocytopenic purpura was related to ticlopidine with a controversial discussion about this association. CASE REPORT: In a 57-year-old female patient, who was admitted with fluctuating central neurological abnormalities and generalized purpura, was made the diagnosis of a thrombotic thrombocytopenic purpura (TTP, Moschcowitz' syndrome). On admission there were a distinct anemia and thrombocytopenia. Corresponding to the hemolysis the laboratory findings showed raised reticulocytes and elevated LDH with > 900 U/l. The peripheral blood smear showed an enrichment of fragmented red cells (15%) and the bone marrow indicated a hyperplastic erythrocytopoesis and a left shift in megakaryocytopoesis. An increase of eosinophilic granulocytes and the tissue basophilic cells directed to a possible allergic phenomenon of the underlying disease. Until 3 weeks before admission she had been on ticlopidine after a left heart catheter with stenting the left coronary artery 6 weeks earlier. Beside taking of acetylsalicylacid and thyroid hormone there was no other regular medication. An early treatment with fresh frozen plasma and plasmapheresis with plasma exchange with fresh frozen plasma led directly to an elevation of thrombocytes and a normalization of hemolytic parameters.
CONCLUSION: This case demonstrates the possible relationship between thrombotic thrombocytopenic purpura and the administration of ticlopidine.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10714127     DOI: 10.1007/bf03044992

Source DB:  PubMed          Journal:  Med Klin (Munich)        ISSN: 0723-5003


  23 in total

1.  Thrombotic thrombocytopenic purpura developed during ticlopidine therapy.

Authors:  G Falezza; D Girelli; O Olivieri; G Gandini; R Corrocher; G De Sandre
Journal:  Haematologica       Date:  1992 Nov-Dec       Impact factor: 9.941

2.  Thrombotic thrombocytopenic purpura and ticlopidine.

Authors:  N Vianelli; G Bandini; L Catani; M Mattioli Belmonte; L Gugliotta
Journal:  Lancet       Date:  1991-05-18       Impact factor: 79.321

Review 3.  The pathophysiology and management of thrombotic thrombocytopenic purpura.

Authors:  P Ruggenenti; G Remuzzi
Journal:  Eur J Haematol       Date:  1996-04       Impact factor: 2.997

4.  Thrombotic thrombocytopenic purpura in a previously splenectomized patient.

Authors:  L R Zacharski; D Lusted; J L Glick
Journal:  Am J Med       Date:  1976-06       Impact factor: 4.965

5.  The association of thrombotic thrombocytopenic purpura with systemic lupus erythematosus: A report of two cases with successful treatment of one.

Authors:  A Dekker; M E O'Brien; R J Cammarata
Journal:  Am J Med Sci       Date:  1974-04       Impact factor: 2.378

6.  Is ticlopidine really responsible for thrombotic thrombocytopenic purpura (TTP)?

Authors:  R Centurioni; M Candela; P Leoni; M L Minnucci; G Danieli
Journal:  Haematologica       Date:  1993 May-Jun       Impact factor: 9.941

7.  Improved survival in thrombotic thrombocytopenic purpura-hemolytic uremic syndrome. Clinical experience in 108 patients.

Authors:  W R Bell; H G Braine; P M Ness; T S Kickler
Journal:  N Engl J Med       Date:  1991-08-08       Impact factor: 91.245

Review 8.  Thrombotic thrombocytopenic purpura: evolution across 15 years.

Authors:  S L Elkins; P P Wilson; J C Files; F S Morrison
Journal:  J Clin Apher       Date:  1996       Impact factor: 2.821

Review 9.  Thrombotic thrombocytopenic purpura and the haemolytic-uraemic syndrome: evolving concepts of pathogenesis and therapy.

Authors:  J J Byrnes; J L Moake
Journal:  Clin Haematol       Date:  1986-05

10.  Thrombohemolytic thrombocytopenic purpura during penicillamine therapy.

Authors:  F Ahmed; V Sumalnop; D M Spain; M S Tobin
Journal:  Arch Intern Med       Date:  1978-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.